NCT00284921: MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive |
|
|
| Terminated | 3 | 60 | Europe | Enteric-coated Mycophenolate sodium (EC-MPS) | Novartis Pharmaceuticals | De Novo Kidney Transplant | 08/06 | | | |
PATRON07, NCT00604357: CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment |
|
|
| Completed | 3 | 27 | Europe | anti-CD 25 mAb, Sirolimus, MMF, Rapamune, Simulect, CellCept, DecortinH | University of Regensburg | End Stage Liver Disease, Impaired Renal Function | 07/11 | 08/12 | | |
